We translate the latest peer-reviewed TMS studies into clear, actionable insights. Below are selected summaries with links to the original write-ups and sources.
Harvard-led data show rTMS augmentation reduced depressive symptoms more than switching to venlafaxine XR, with response/remission advantages over aripiprazole augmentation.
Overview of Deep TMS (H-coil) vs. first-generation figure-8 coils, summarizing clinical evidence and practical considerations drawn from BrainsWay resources.
Follow-up data indicate durable remission in TRD after acute TMS, with low relapse rates when maintenance (taper, pharmacotherapy, or additional TMS) is applied.
In veterans, deep TMS was associated with sustained reductions in depression, PTSD symptoms, and suicidal ideation through 6-month follow-up.